Disc Medicine Inc. IRON
$69.86
▼ -0.13% 24H
About
Disc Medicine Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It targets fundamental biological pathways associated with the formation and function of red blood cells, particularly heme biosynthesis and iron ho…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees154
TickerIRON
Statistics
Market Cap$2.67B
Revenue (TTM)$0
Net Income-$212.2M
Net Margin—
EPS$-6.01
P/E4.99
P/S—
P/B3.73
EV/EBITDA-7.07
ROE-35.8%
Dividend Yield—
Price$69.86
Data: Twelve Data · Revenue = mcap / P/S